4d Molecular Therapeutics, Inc. · NASDAQ:FDMT
Janus Henderson Group PLC reported a 10.30% stake in 4d Molecular Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed Apr 7, 2026
Janus Henderson Group PLC reported a 10.30% stake in 4d Molecular Therapeutics, Inc., 5,247,151 shares, as a passive investor on Mar 31, 2026. Filed Apr 7, 2026 (Schedule 13G/A).
- Stake
- 10.30%
- Shares
- 5,247,151
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 10.30% | 5,247,151 |
Source
Related
- 4d Molecular Therapeutics, Inc.
- Janus Henderson Group PLC
- 4d Molecular Therapeutics, Inc. shareholders
- Schedule 13G · Janus Henderson Group PLC · Feb 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Feb 14, 2025
- Form 4 · Bizily Scott · Oct 20, 2026
- Form 4 · Kirn David · Oct 7, 2026
- Form 4 · Bizily Scott · Sep 22, 2026
- Form 4 · Kirn David · Sep 16, 2026
- Form 4 · Bizily Scott · Sep 3, 2026